160 related articles for article (PubMed ID: 31692072)
1. Upregulated calcium-binding tyrosine phosphorylation-regulated protein-a/b regulates cell proliferation and apoptosis and predicts poor prognosis in hepatocellular carcinoma.
Yu XN; Guo HY; Liu TT; Zhang GC; Zhu HR; Shi X; Song GQ; Jiang XM; Huang XX; Weng SQ; Dong L; Shen XZ; Huang YQ; Zhu JM
J Cell Biochem; 2020 Apr; 121(4):2938-2949. PubMed ID: 31692072
[TBL] [Abstract][Full Text] [Related]
2. The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma.
Li H; Fang L; Xiao X; Shen L
Bull Cancer; 2012 Mar; 99(3):E26-33. PubMed ID: 22285430
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
4. BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1.
Tu K; Liu Z; Yao B; Xue Y; Xu M; Dou C; Yin G; Wang J
Oncol Rep; 2016 Apr; 35(4):2382-90. PubMed ID: 26882953
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY
Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
7. Sp1-regulated transcription of RasGRP1 promotes hepatocellular carcinoma (HCC) proliferation.
Zhang X; Zhuang H; Han F; Shao X; Liu Y; Ma X; Wang Z; Qiang Z; Li Y
Liver Int; 2018 Nov; 38(11):2006-2017. PubMed ID: 29655291
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
9. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
Wang C; Yao B; Xu M; Zheng X
Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinoma.
He L; Fan X; Li Y; Chen M; Cui B; Chen G; Dai Y; Zhou D; Hu X; Lin H
Cell Death Dis; 2019 Jun; 10(6):444. PubMed ID: 31168049
[TBL] [Abstract][Full Text] [Related]
11. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.
Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P
Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668
[TBL] [Abstract][Full Text] [Related]
12. Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma.
Yu XN; Zhang GC; Sun JL; Zhu HR; Shi X; Song GQ; Weng SQ; Dong L; Liu TT; Shen XZ; Guo HY; Zhu JM
Ann Surg Oncol; 2020 May; 27(5):1546-1557. PubMed ID: 32157528
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of snoRNA SNORA52 and Its Clinical Significance in Hepatocellular Carcinoma.
Ding Y; Sun Z; Zhang S; Li Y; Han X; Xu Q; Zhou L; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W
Biomed Res Int; 2021; 2021():7020637. PubMed ID: 34195281
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
15. IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.
Liu R; Tang C; Shen A; Luo H; Wei X; Zheng D; Sun C; Li Z; Zhu D; Li T; Wu Z
Oncotarget; 2016 Dec; 7(51):85079-85096. PubMed ID: 27835881
[TBL] [Abstract][Full Text] [Related]
16. Oncogene RPA1 promotes proliferation of hepatocellular carcinoma via CDK4/Cyclin-D pathway.
Wang J; Yang T; Chen H; Li H; Zheng S
Biochem Biophys Res Commun; 2018 Apr; 498(3):424-430. PubMed ID: 29477843
[TBL] [Abstract][Full Text] [Related]
17. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
Reiter FP; Denk G; Ziesch A; Ofner A; Wimmer R; Hohenester S; Schiergens TS; Spampatti M; Ye L; Itzel T; Munker S; Teufel A; Gerbes AL; Mayerle J; De Toni EN
Cell Oncol (Dordr); 2019 Oct; 42(5):705-715. PubMed ID: 31250364
[TBL] [Abstract][Full Text] [Related]
18. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
[TBL] [Abstract][Full Text] [Related]
19. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
20. Expression of the sperm fibrous sheath protein CABYR in human cancers and identification of α-enolase as an interacting partner of CABYR-a.
Tseng YT; Hsia JY; Chen CY; Lin NT; Chong PC; Yang CY
Oncol Rep; 2011 Apr; 25(4):1169-75. PubMed ID: 21274509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]